National Institutes of Health
The National Institutes of Health (NIH) is a US federal agency funding biomedical research grants & programs.
NIH Grants: Improve Care for Complex Health Needs
Are you a researcher or healthcare provider focused on improving care for patients with multiple chronic conditions who face health disparities? This grant funds innovative, collaborative projects to adapt and implement best practices in healthcare models, aiming to achieve health equity.
NIH Funding: Cut Joint Pain & Innovate Treatments
NIH is seeking interdisciplinary teams to form a consortium focused on understanding the sensory neurons in joints that cause pain. This funding supports research to identify new targets for developing innovative treatments to reduce joint pain.
Boost Pain Research: NIH Funding for New Scientists
Seeking to build the next generation of pain researchers and foster collaboration, this NIH initiative provides funding for a coordinating center to train and mentor early-stage investigators. The goal is to accelerate the development of innovative, non-opioid pain management solutions through interdisciplinary teamwork.
Alzheimer's Research Grants: Fund Your Breakthrough
This grant supports early to late-stage clinical trials for new Alzheimer's and age-related cognitive decline treatments. Businesses can receive funding for developing and implementing promising pharmacological and non-pharmacological interventions, as well as improving trial methodologies.
NIH Grant: Boost Health Research & Student Training
Are you a health professional or graduate school with limited NIH funding? This grant offers support for small-scale biomedical research projects, focusing on hands-on experience for your students and improving your institution's research capabilities.
NIH Grants: Fund Your Alzheimer's Research!
Seeking innovative pilot studies for Alzheimer's disease and related dementias? This grant funds early-stage research on treatments for cognitive decline, helping to advance clinical trial design and methods.
Unlock Funding: Accelerate Drug Abuse Research with NIH Grants
NIH invites applications from researchers to analyze existing data for innovative studies on drug use, prevention, and treatment strategies. This grant aims to boost knowledge in understanding the causes, consequences, and effective interventions for substance abuse and related disorders.
NIH Grant: Fund Your Cancer Tech Innovations!
Are you developing advanced technologies to improve cancer biospecimen quality? This NIH grant supports proof-of-concept projects for tools, devices, and methods that ensure sample integrity and utility for cancer research.
Fund Your Cancer Tech: NIH Grants for Innovation
NIH is funding early-stage development of groundbreaking molecular analysis technologies for cancer research. This grant is for innovators creating new tools with the potential to revolutionize cancer biology, diagnosis, and treatment.
Fund Cancer Tech: Advance Molecular Analysis
NIH is seeking applications to advance and validate cutting-edge molecular analysis technologies for cancer research. This funding supports technologies with proven potential to significantly impact cancer biology, treatment, diagnosis, and prevention.
Unlock NIH Funding for Biospecimen Tech Innovation
Are you developing cutting-edge technologies to improve cancer biospecimen quality and utility? This NIH grant supports early-stage feasibility studies for innovative tools, devices, and methods that enhance biospecimen handling and assessment.
NIH Grants: Fund Pain Treatment Innovation
This NIH initiative is for researchers and businesses looking to discover and validate new targets for developing safe and effective pain treatments. Funding supports basic science research to identify novel therapeutic targets with minimal side effects and addiction potential.
Get NIH Funding for Aging Research!
Researchers and institutions focused on aging can apply for renewal or revision grants to advance their studies. This funding supports innovative projects in aging research.
Unlock Funding for Novel Vaccine Development
This grant supports research centers focused on developing new vaccines and immunization strategies for Clostridioides difficile infection. Businesses contributing to the understanding of host immunity and exploring new vaccine platforms can receive significant funding.
Get Funding for Stroke Research & Drug Development
This NIH grant funds a coordinating center to oversee the testing of up to 6 promising neuroprotective drugs for acute ischemic stroke. Businesses involved in preclinical stroke research and drug development can apply to help bridge the gap between lab discoveries and clinical trials.
Get Funding for Blood Science Research Independence
This program is for physician scientists in blood science who have completed their mentored K99/R00 award. It provides a clear path to independent research funding focused on blood diseases and resources.
Get Funding for Stroke Intervention Research!
Small businesses with promising cerebroprotective interventions can receive funding to test their groundbreaking therapies in preclinical stroke models. This initiative aims to accelerate the development of life-saving stroke treatments and bridge the gap to clinical trials.
Get Grants for Minority Health Innovations!
United States small businesses can get funding to develop innovative, affordable, and culturally relevant technologies that improve minority health and eliminate health disparities.
Get Funding for Stroke Treatment Research
This grant opportunity is for testing laboratories looking to accelerate the development of new stroke treatments. You can receive funding to test promising cerebroprotective drugs and interventions in preclinical models, helping to bridge the gap to clinical trials.
NIH Grant: Fund Your Stroke Intervention Research!
This NIH grant funds promising cerebroprotective drugs and interventions to be tested in stroke research models, potentially accelerating therapies for clinical trials. It's ideal for researchers with strong preliminary data seeking to bridge the gap between preclinical development and patient testing.